Transient hyperthyroidism of hyperemesis gravidarum
|
|
- Colleen York
- 5 years ago
- Views:
Transcription
1 BJOG: an International Journal of Obstetrics and Gynaecology June 2002, Vol. 109, pp Transient hyperthyroidism of hyperemesis gravidarum Jackie Y.L. Tan a, *, Keh Chuan Loh b, George S.H. Yeo c, Yam Cheng Chee a Objective To characterise the clinical, biochemical and thyroid antibody profile in women with transient hyperthyroidism of hyperemesis gravidarum. Design Prospective observational study. Setting Hospital inpatient gynaecological ward. Population Women admitted with hyperemesis gravidarum and found to have hyperthyroidism. Methods Fifty-three women were admitted with hyperemesis gravidarum and were found to have hyperthyroidism. Each woman was examined for clinical signs of thyroid disease and underwent investigations including urea, creatinine, electrolytes, liver function test, thyroid antibody profile and serial thyroid function test until normalisation. Main outcome measures Gestation at which thyroid function normalised, clinical and thyroid antibody profile and pregnancy outcome (birthweight, gestation at delivery and Apgar score at 5 minutes). Results Full data were available for 44 women. Free T4 levels normalised by 15 weeks of gestation in the 39 women with transient hyperthyroidism while TSH remained suppressed until 19 weeks of gestation. None of these women were clinically hyperthyroid. Thyroid antibodies were not found in most of them. Median birthweight in the infants of mothers who experienced weight loss of > 5% of their pre-pregnancy weight was lower compared with those of women who did not ( P ¼ 0.093). Five women were diagnosed with Graves disease based on clinical features and thyroid antibody profile. Conclusions In transient hyperthyroidism of hyperemesis gravidarum, thyroid function normalises by the middle of the second trimester without anti-thyroid treatment. Clinically overt hyperthyroidism and thyroid antibodies are usually absent. Apart from a non-significant trend towards lower birthweights in the infants of mothers who experienced significant weight loss, pregnancy outcome was generally good. Routine assessment of thyroid function is unnecessary for women with hyperemesis gravidarum in the absence of any clinical features of hyperthyroidism. INTRODUCTION Transient hyperthyroidism occurs in up to two-thirds of women with hyperemesis gravidarum 1. Although the cause of transient hyperthyroidism is not completely understood, human chorionic gonadotropin (hcg) is likely to play a central role in its pathogenesis. Structural homology exists not only between hcg and thyroid stimulating hormone (TSH) but also between their receptors, forming the basis of the cross reactivity. The thyrotropic action of hcg has been demonstrated clearly in various studies 2 4. Further evidence comes from clinical studies which have reported higher hcg levels in women with hyperemesis gravidarum and other studies which have shown a positive correlation a Department of General Medicine, Tan Tock Seng Hospital, Singapore b Endocrine Unit, Tan Tock Seng Hospital, Singapore c Department of Maternal Fetal Medicine, KK Women s and Children s Hospital, Singapore * Correspondence: Dr J. Y. L. Tan, Department of General Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore D RCOG 2002 BJOG: an International Journal of Obstetrics and Gynaecology PII: S (0 2) between hcg levels and the severity of vomiting and the degree of thyroid stimulation 5,6. The aim of our study was to characterise the clinical, biochemical and thyroid antibody profile in women with transient hyperthyroidism of hyperemesis gravidarum. METHODS Hyperemesis gravidarum is defined as persistent vomiting, with onset occurring before 13 weeks of gestation, of such severity that the woman is unable to retain solids and liquids and requires hospital admission for intravenous hydration. Assessment of thyroid function was performed in women who had a protracted course (defined as hospitalisation exceeding the average length of stay for hyperemesis gravidarum which was three days at our institution) or in those who required recurrent admissions (defined as two or more admissions). No other cause for vomiting was found after careful examination and relevant investigations. Each woman was also examined for signs of thyroid disease and clinical thyroid status by the same physician with particular attention to the following features: resting pulse rate after adequate hydration, weight,
2 684 J.Y.L. TAN ET AL. Table 1. Characterisitcs of 39 women with transient hyperthyroidism. Characteristics Racial distribution n (%) Chinese 14 (35.9) Malays 13 (33.3) Indians 11 (28.2) Others 1 (2.6) Mean age (years) F SD 29.6 F 5.6 (range 19 40) Parity n (%) 0 16 (41.0) 1 11 (28.2) 2 7 (18.0) 3 5 (12.8) Mean gestation (weeks) at presentation F SD 9.2 F 1.9 (range 6 13) Number of admissions n (%) 1 19 (48.7) 2 8 (20.5) 3 12 (30.8) goitre, Graves ophthalmopathy and dermopathy. Pelvic ultrasound was performed to confirm gestational age and to exclude molar pregnancy. The following tests were done: urea, creatinine, electrolytes, liver function test, TSH receptor antibody, thyroid peroxidase antibody and thyroglobulin antibody and serial free thyroxine (T4) and TSH until normalisation. Free T4 and TSH were performed using a commercial kit (Abbott Axsym based on MEIA; functional TSH sensitivity of 0.06 miu/l). Hyperthyroidism was defined as TSH level of <0.1 miu/l and free T4 level of >26 pmol/l. A diagnosis of Graves disease was made if additional features were present: significantly elevated TSH receptor antibody >10 U/L or thyroid peroxidase antibody, diffuse goitre, Graves ophthalmopathy or dermopathy. The pregnancy outcomes studied included birthweight, gestation at delivery and Apgar score at five minutes. Comparison of birthweights between women who experienced significant weight loss (defined as >5% of the pre-pregnancy weight) and those who did not was made using non-parametric Mann Whitney U test. RESULTS Over a period of 18 months, 87 women hospitalised for hyperemesis gravidarum underwent thyroid function testing of whom 53 (60.9%) were identified to have hyperthyroidism. Nine women had incomplete follow up and were excluded from the study. Among the remaining 44 women, 39 were diagnosed with transient hyperthyroidism of hyperemesis gravidarum and five with Graves disease. Demographic data of the women with transient hyperthyroidism of hyperemesis gravidarum and Graves disease are shown in Tables 1 and 2, respectively. The proportion of Malay and Indian women with hyperemesis gravidarum appears to be greater than that which would be expected based on the country s racial distribution of Chinese, Malays and Indians. However, this can be explained by the fact that these figures parallel and reflect the racial composition of the hospital s obstetric population. In the group of 39 women with transient hyperthyroidism of hyperemesis gravidarum, biochemical investigations at initial presentation revealed hyponatraemia in 66.7%, hypokalaemia in 59%, raised aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) levels in 56.4% and raised total bilirubin in 12.8%, reflecting the severity of hyperemesis gravidarum (Table 3). The pattern of abnormal liver function test was that of mild to moderate elevation in AST and ALT and mild hyperbilirubinaemia. Viral hepatitis screen was negative in the women with abnormal liver function test. Free T4 levels normalised by 15 weeks of gestation in all without any anti-thyroid treatment (Fig. 1). TSH levels, however, remained suppressed for a longer period up to 19 weeks of gestation (Fig. 2). None of the women had clinically overt hyperthyroidism although 56% demonstrated significant weight loss. Mildly elevated thyroglobulin antibody and thyroid peroxidase antibody levels were seen in one and two women, respectively, but none had TSH receptor antibody level of >10 U/L. There were 35 singleton pregnancies and four twin pregnancies in the group of women with transient hyperthyroidism of hyperemesis gravidarum. In the singleton pregnancy group, 19 women underwent vaginal delivery, nine caesarean section, two had elective termination in the first trimester for social reasons, four delivered abroad or in other hospitals and one had a miscarriage at 15 weeks Table 2. Characteristics of five women with Graves disease. Patient Parity Goitre Other signs TRAb* TPOAb* TgAb* MTLG (30 years/chinese) 1 Present BBAB (28 years/malay) 1 Present 3.3 > KS (27 years/indian) 4 Present LFK (30 years/chinese) 1 Present Proptosis Tachycardia (120/minute) CWC (33 years/chinese) 2 Absent Tachycardia (122/minute) * Normal cutoff values: TSH receptor antibody <10 U/L; thyroid peroxidase antibody 0.3 U/mL; thyroglobulin antibody 0.3 U/mL.
3 TRANSIENT HYPERTHYROIDISM OF HYPEREMESIS GRAVIDARUM 685 Table 3. Biochemical and thyroid antibody profile in 39 women with transient hyperthyroidism. Values are given as n (%) unless otherwise shown. Biochemical abnormalities/thyroid antibody profile No. of patients Range of abnormal values Hyponatraemia (Na <135 mmol/l) 26 (66.7) mmol/l Hypokalaemia (K <3.5 mmol/l) 23 (59) mmol/l AST and/or ALT (>40 U/L) 22 (56.4) AST U/L ALT U/L Total bilirubin (>24 umol/l) 5 (12.8) umol/l TSH receptor antibody (>10 U/L) 0 (0) Thyroid peroxidase antibody (>0.3 U/mL) 2 (5.1) U/mL Thyroglobulin antibody (>0.3 U/mL) 1 (2.6) 7.7 U/mL of gestation because of chorioamnionitis. There were no preterm (before 37 weeks of gestation) deliveries. Median gestation at delivery was 39 weeks and median birthweight was 2970 g (Table 4). When the women were subdivided into those who experienced significant weight loss and those who did not, median birthweights were 2915 and g, respectively ( P ¼ 0.093). There was a preponderance of female babies with a female-tomale ratio of 2.6:1. In the twin pregnancy group, median gestation at delivery was 37 weeks and median birthweight was g. Three women delivered by the vaginal route and one underwent caesarean section. The ratio of female to male babies was 3:1 (Table 4). None of the babies from both groups had an Apgar score of 7 at 5 minutes. Five women were diagnosed with Graves disease based on clinical features already described. Four women had diffuse goitre, two had persistent tachycardia of 120/ minute (even after hydration) and one had proptosis (Table 2). Two women had hyponatraemia and one had abnormal liver function test. There was a positive family history of thyroid disease in one of the women. Propylthiouracil was started in two women who were overtly hyperthyroid. Treatment was not started in the remaining three women because they were not overtly hyperthyroid and also because there was spontaneous improvement in their thyroid function. Postnatally, one of these women developed postpartum thyroiditis and later suffered a relapse of Graves disease. DISCUSSION There exists a spectrum of abnormal thyroid function test caused by pregnancy. In the first and early second trimesters of pregnancy, hcg with its thyrotropic activity, albeit a weak one, plays an important role. In most normal pregnant women, the thyroid stimulatory effect of hcg is minor and short lived. In a study that looked at TSH blunting in a large group of pregnant women during the three trimesters, 18% of women in the first trimester had transiently subnormal TSH levels (as well as higher mean hcg levels) with almost half being undetectable (<0.05 mu/l). Eleven percent of the women with undetectable TSH levels also had elevated free T4 levels 7. Isolated TSH suppression therefore forms one end of this spectrum followed by the additional finding of elevated free T4 levels and finally, transient hyperthyroidism of hyperemesis gravidarum. Goodwin et al. 1 reported that 66% of women with hyperemesis gravidarum had biochemical hyperthyroidism or suppressed TSH and that the severity of hyperemesis varied directly with the degree of hyperthyroidism. In this study, we looked at the Table 4. Pregnancy outcome in 39 women with transient hyperthyroidism. Pregnancy outcome Singleton pregnancy (n ¼ 35) Twin pregnancy (n ¼ 4) Median gestation (weeks) at delivery 39 (range 37 40) 37 (range 35 38) Mode of delivery: n (%) Vaginal delivery 19 (54.3) 3 (75) Caesarean section 9 (25.7) 1 (25) Termination 2 (5.7) 0 (0) Others 1 (2.9) 0 (0) Delivered abroad/in other hospitals 4 (11.4) 0 (0) Birthweight (g) Mean Median 2970 (range ) (range ) Female:male ratio 2.6:1 3:1
4 686 J.Y.L. TAN ET AL. Fig. 1. Mean free T4 levels by gestation. *Mean free T4 levels established in the normal population. **Mean free T4 levels in women with hyperemesis gravidarum. clinical, biochemical and thyroid antibody profile of a group of women at the extreme end of this spectrum, i.e., with both hyperemesis gravidarum and hyperthyroidism, and attempted to establish the clinical characteristics which could help distinguish between transient hyperthyroidism of hyperemesis gravidarum and Graves disease. Most of the women in the study had transient hyperthyroidism of hyperemesis gravidarum and only 11% were diagnosed with Graves disease. This is not unexpected as the initial presentation of Graves disease in pregnancy is unusual. However, it can still occur for the first time because it is well known that exacerbation of Graves disease may develop in the first and early second trimesters of pregnancy due to the thyroid stimulatory effect of hcg. In the transient hyperthyroidism of hyperemesis gravidarum group, all of the women were clinically euthyroid. Previous studies have similarly reported that women with transient hyperthyroidism of hyperemesis gravidarum lack clinical features of hyperthyroidism 1. A plausible explanation may be that the duration of increased thyroid function is relatively brief and transient such that there is insufficient time for the development of clinically overt hyperthyroidism. Indeed, these dynamic changes in thyroid Fig. 2. Percentage of TSH <0.1 miu/l by gestation.
5 TRANSIENT HYPERTHYROIDISM OF HYPEREMESIS GRAVIDARUM 687 function, particularly in free T4 levels, were observed in our study when we performed serial measurements. Others have suggested that peripheral conversion to triiodothyronine (T3) is spared based on the finding of less frequently elevated free T3 index as compared with free T4 index 1. In a study on serum levels of reverse T3 in hyperemesis gravidarum, results were consistent with a shift from T3 to rt3 production. As rt3 is physiologically inactive, this mechanism may account for the lack of clinical hyperthyroidism 8. Two useful clinical features which helped to distinguish between transient hyperthyroidism of hyperemesis gravidarum and Graves disease were the presence of goitre (in an iodine replete population) and severe tachycardia of 120/ minute. Goitre was found in four and severe tachycardia in two of the five women with Graves disease, whereas both features were not observed in any of the women with transient hyperthyroidism of hyperemesis gravidarum. Weight loss was a poor discriminator with 56% and 26% of women with transient hyperthyroidism of hyperemesis gravidarum and Graves disease respectively demonstrating significant loss. In our study, free T4 levels normalised by 15 weeks of gestation in women with transient hyperthyroidism of hyperemesis gravidarum. TSH remained suppressed for a longer period up to 19 weeks of gestation. None of the women required treatment with anti-thyroid medication. This is consistent with other studies which have reported that resolution of hyperthyroidism occurs within a time frame of 1 10 weeks 1. Glinoer et al. 7 showed that hcg remained abnormally elevated for several weeks during the second trimester and that normalisation of free T4 levels paralleled the decline in hcg, supporting its role in the pathogenesis of transient hyperthyroidism of hyperemesis gravidarum. Unfortunately, our study did not look at hcg levels. Lower birthweights have been observed in infants born to mothers with hyperemesis gravidarum, particularly in the group of women who experience significant weight loss where there appears to be a greater risk of intrauterine growth restriction 9,10. The mean birthweight in singleton pregnancies ( g) was lower than the population mean of 3100 g, but whether this is directly related to hyperemesis gravidarum alone or of any clinical significance remains unknown. Birthweight is affected by multiple factors and it was not the primary purpose of our study to address these factors. The trend towards lower birthweights, particularly in the infants of women who experienced significant weight loss, may however highlight the need for closer monitoring of fetal growth in this group. Due to the benign nature of transient hyperthyroidism of hyperemesis gravidarum with respect to maternal and fetal outcomes, our data support that routine thyroid function testing is not necessary for all women with hyperemesis gravidarum. The transient biochemical abnormality normalises spontaneously by mid-gestation and does not alter management of these women. Graves disease, which is the most common cause of hyperthyroidism in our population, can generally be diagnosed based on clinical features as was demonstrated in our study. Thyroid antibody testing provides further confirmation. There was a preponderance of female babies born to mothers with a ratio of 2.6 3:1. This has also been observed in other studies on hyperemesis gravidarum The common factor appears to be high hcg levels which, in addition to its thyrotropic effect, has been hypothesised to support female conceptions. In normal pregnancies, a female fetus is associated with higher concentrations of hcg at birth than a male fetus although the concentrations in early pregnancy are not known 14. Further evidence comes from studies that show a significant excess of female infants born after hormonal induction of ovulation with hcg 15. CONCLUSION In conclusion, hyperthyroidism associated with hyperemesis gravidarum is of a transient nature where free T4 levels normalise by 15 weeks of gestation without antithyroid treatment. TSH levels remained suppressed for a longer period. Clinically overt hyperthyroidism and thyroid antibodies are usually absent in these women. The presence of certain clinical signs, significantly elevated thyroid antibodies and persistence of thyroid function abnormalities beyond the gestation that is observed for transient hyperthyroidism of hyperemesis gravidarum helps to distinguish the woman with Graves disease. Apart from a non-significant trend towards lower birthweights in the infants of mothers who experienced weight loss, pregnancy outcome was generally good. Due to the benign nature of transient hyperthyroidism of hyperemesis gravidarum, we suggest that routine assessment of thyroid function is unnecessary for women with hyperemesis gravidarum and should be confined only to those who demonstrate clinical features of hyperthyroidism. References 1. Goodwin TM, Montro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992;167: Hershman JM, Lee H-Y, Sugawara M, et al. Human chorionic gonadotropin stimulates iodide uptake, adenylate cyclase and deoxyribonucleic acid synthesis in cultured rat thyroid cells. J Clin Endocrinol Metab 1988;67: Yamazaki K, Sato K, Shizume K, et al. Potent thyrotropic activity of human chorionic gonadotropin variants in terms of 125 I incorporation and de novo synthesized thyroid hormone release in human thyroid follicles. J Clin Endocrinol Metab 1995;80: Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid 1995;5: Mori M, Amino N, Tamako H, Miyai K, Tanizawa O. Morning
6 688 J.Y.L. TAN ET AL. sickness and thyroid function in normal pregnancy. Obstet Gynecol 1988;72: Goodwin TM, Hershman JM, Cole L. Increased concentration of the free h-subunit of human chorionic gonadotropin in hyperemesis gravidarum. Acta Obstet Gynecol Scand 1994;73: Glinoer D, De Nayer PP, Robyn C, et al. Serum levels of intact human chorionic gonadotropin (HCG) and its free a and h subunits in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 1993;16: Asakura H, Watanabe S, Sekiguchi A, Power GG, Araki T. Severity of hyperemesis gravidarum correlates with serum levels of reverse T3. Arch Gynecol Obstet 2000;264: Chin RK, Lao TT. Low birth weight and hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 1988;28: Gross S, Librach C, Cecutti A. Maternal weight loss associated with hyperemesis gravidarum: a predictor of fetal outcome. Am J Obstet Gynecol 1989;160: Askling J, Erlandsson G, Kaijser M, Akre O, Ekbom A. Sickness in pregnancy and sex of child. Lancet 1999;354: Hsu CD, Witter FR. Fetal sex and severe hyperemesis gravidarum. Int J Gynaecol Obstet 1993;40: del Mar Melero-Montes M, Jick H. Hyperemesis and the sex of the offspring. Epidemiology 2001;12: Danzer H, Braustein GD, Rasor K, Forsythe A, Wade ME. Maternal serum human chorionic gonadotropin concentrations and fetal sex prediction. Fertil Steril 1980;34: James WH. The sex ratio of infants born after hormonal induction of ovulation. Br J Obstet Gynaecol 1985;92: Accepted 30 January 2002
Thyrotoxicosis in Pregnancy: Diagnose and Management
Thyrotoxicosis in Pregnancy: Diagnose and Management Yuanita Asri Langi email: meralday@yahoo.co.id Endocrinology & Metabolic Division, Internal Medicine Department, Prof.dr.R.D. Kandou Hospital/ Sam Ratulangi
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy Early diagnosis and good management of maternal thyroid dysfunction are essential to ensure minimal adverse effects on
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationLecture title. Name Family name Country
Lecture title Name Family name Country Nguyen Thy Khue, MD, PhD Department of Endocrinology HCMC University of Medicine and Pharmacy, MEDIC Clinic Hochiminh City, Viet Nam Provided no information regarding
More informationTHE PHARMA INNOVATION - JOURNAL Assessment of Antithyroperoxidase Antibodies and Thyroid Hormones Among Sudanese Pregnant Women
Received: 01-09-2013 Accepted: 30-09-2013 ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 2 No. 9 2013 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION
More informationUpdate on Gestational Thyroid Disease. Aidan McElduff The Discipline of Medicine, The University of Sydney
IADPSG 2016 Update on Gestational Thyroid Disease Aidan McElduff The Discipline of Medicine, The University of Sydney IADPSG 2016 DISCLOSURES and AIM Nil to disclose Aim: to provide an overview 2017 Guidelines
More informationOvert and subclinical hypothyroidism among Bangladeshi pregnant women and its effect on fetomaternal outcome
Bangladesh Med Res Counc Bull 21; : 52-57 Overt and subclinical hypothyroidism among Bangladeshi pregnant women and its effect on fetomaternal outcome Sharmeen M, Shamsunnahar A, Laita TR, Chowdhury SB
More informationHypothyroidism in pregnancy. Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah
Hypothyroidism in pregnancy Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah Agenda 1. Epidemiology and clinical characteristics of maternal hypothyroidism 2. Prevention and
More informationThe Thyroid and Pregnancy OUTLINE OF DISCUSSION 3/19/10. Francis S. Greenspan March 19, Normal Physiology. 2.
The Thyroid and Pregnancy Francis S. Greenspan March 19, 2010 OUTLINE OF DISCUSSION 1. Normal Physiology 2. Hypothyroidism 3. Hyperthyroidism 4. Thyroid Nodules and Cancer NORMAL PHYSIOLOGY Iodine Requirements:
More informationThyroid Function Before and After Induced Abortion in Normal Pregnant Women
Endocrinol Japon 1992, 39 (1), 13-17 Thyroid Function Before and After Induced Abortion in Normal Pregnant Women HIDEO HARA, YOSHIO BAN, YOSHIO MORITA, AND RYUJI SATO The 3rd Department of Internal Medicine,
More informationBELIEVE MIDWIFERY SERVICES
TITLE: THYROID DISEASE IN PREGNANCY EFFECTIVE DATE: July, 2013 POLICY STATEMENT: Pregnancy changes significantly the values influenced by the serum thyroid binding hormone level (i.e., total thyroxine,
More informationReview Article Think Thyroid - Think Life: Pregnancy with Thyroid Disorders
Chettinad Health City Medical Journal Muthukumaran Jayapaul* Consultant Endocrinologist, Arka Center for Hormonal Health, Chennai, India Dr. Muthu Kumaran Jayapaul is a Consultant Endocrinologist and also
More informationApproach to thyroid dysfunction
Approach to thyroid dysfunction Alice Y.Y. Cheng, MD, FRCPC Twitter: @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or
More informationThyroid disorders in antenatal women in a rural hospital in central India
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Mahajan KS et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jan;5(1):62-67 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationThyroid Disease in Pregnancy: The Essentials. Elizabeth N. Pearce, MD, MSc
Thyroid Disease in Pregnancy: The Essentials Elizabeth N. Pearce, MD, MSc None Disclosures Case 1 A 31-year-old woman from Massachusetts is practicing a vegan diet. She is currently planning a pregnancy.
More informationReview Article Management of Hyperthyroidism in Pregnancy: Comparison of Recommendations of American Thyroid Association and Endocrine Society
Thyroid Research Volume 2013, Article ID 878467, 6 pages http://dx.doi.org/10.1155/2013/878467 Review Article Management of Hyperthyroidism in Pregnancy: Comparison of of American Thyroid Association and
More informationNeonatal Thyrotoxicosis Management of babies born to mothers with a history of hyperthyroidism (Grave s Disease)
MCN for Neonatology West of Scotland Neonatal Guideline Neonatal Thyrotoxicosis Management of babies born to mothers with a history of hyperthyroidism (Grave s Disease) This document is applicable to all
More informationEVALUATION OF THYROID FUNCTION IN PRE-ECLAMPSIA
EVALUATION OF THYROID FUNCTION IN PRE-ECLAMPSIA K. Sunanda 1, P. Sravanthi 2, H. Anupama 3 1Assistant Professor, Department of Obstetrics & Gynaecology, Gandhi Medical College/Hospital. 2Post Graduate,
More informationEsther Briganti. Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy. Endocrinologist and Clinician Researcher
Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy Esther Briganti Endocrinologist and Clinician Researcher Director, Melbourne Endocrine Associates Associate Professor,
More informationHyperthyroidism and Hypothyroidism in Pregnancy Guideline
Aneurin Bevan University Health Board Hyperthyroidism and Hypothyroidism in Pregnancy Guideline N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed
More informationUnderstanding thyroid function tests. Dr. Colette George
Understanding thyroid function tests Dr. Colette George Disclosures No financial disclosure I will present fictitious cases and thyroid function tests (TFTs) that are based on scenarios I commonly encounter.
More informationThyroid function testing in pregnancy: 2017 ATA guidelines update. Dr Simon Forehan
Thyroid function testing in pregnancy: 2017 ATA guidelines update Dr Simon Forehan Several factors are known to tax gravid thyroid economy: Increased plasma volume TBG pool increased Renal clearance Feto-placental
More informationClinical Guideline MANAGEMENT OF INFANTS BORN TO MOTHERS WITH GRAVES DISEASE AND AT RISK OF THYROTOXICOSIS
Clinical Guideline MANAGEMENT OF INFANTS BORN TO MOTHERS WITH GRAVES DISEASE AND AT RISK OF THYROTOXICOSIS Date of First Issue 18/07/2016 Approved 28/09/2017 Current Issue Date 16/06/2017 Review Date 01/09/2019
More informationMaternal and perinatal outcome in antenatal women with hypothyroidism
Original Research Article Maternal and perinatal outcome in antenatal women with hypothyroidism Polumuru Usha Devi 1, Gundu Vanaja 1* 1 Assistant Professor of Obstetrics and Gynecology, Andhra Medical
More informationHyperthyroidism Diagnosis and Treatment. April Janet A. Schlechte, M.D.
Hyperthyroidism Diagnosis and Treatment Family Practice Refresher Course April 2015 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Thyroid Status in First Trimester of Pregnancy-A Hospital Based Study Saurabh Borkotoki 1*,
More informationLow concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation?
BJOG: an International Journal of Obstetrics and Gynaecology September 2004, Vol. 111, pp. 925 930 DOI: 10.1111/j.1471-0528.2004.00213.x Low concentrations of maternal thyroxin during early gestation:
More informationNIH Public Access Author Manuscript Ther Drug Monit. Author manuscript; available in PMC 2013 April 14.
NIH Public Access Author Manuscript Published in final edited form as: Ther Drug Monit. 2006 February ; 28(1): 8 11. Thyroid Function Testing in Pregnancy and Thyroid Disease: Trimester-specific Reference
More informationmolecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011
molecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011 Case Vignette A 25-year old man was admitted to our hospital because of fever, productive cough, nausea and weight loss. The patient had
More informationThyroid function in pregnancy
Published Online December 23, 2010 Thyroid function in pregnancy John H. Lazarus * Centre for Endocrine and Diabetes Sciences, Cardiff University School of Medicine, University Hospital of Wales, Heath
More informationThis is the author s final accepted version.
Carty, D. M., Doogan, F., Welsh, P., Dominiczak, A. F., and Delles, C. (2017) Thyroid stimulating hormone (TSH) 2.5mU/l in early pregnancy: prevalence and subsequent outcomes. European Journal of Obstetrics
More informationA descriptive study of the prevalence of hypothyroidism among antenatal women and foetal outcome in treated hypothyroid women
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Prasad DR et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jun;5(6):1892-1896 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationScreening Babies at risk of Congenital Hyperthyroidism GL354
1 Screening Babies at risk of Congenital Hyperthyroidism GL354 Approval and Authorisation Approved by Job Title Date Paediatric Clinical Governance Chair of paediatric Clinical Governance March 2016 Change
More informationScreening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health(review)
Cochrane Database of Systematic Reviews Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health(review) SpencerL,BubnerT,BainE,MiddletonP
More informationJMSCR Vol 04 Issue 03 Page March 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i3.60 Thyroid Dysfunction and Pregnancy Outcome
More informationShould every pregnant woman be screened for thyroid disease?
Should every pregnant woman be screened for thyroid disease? Tal Biron-Shental Rinat Gabbay-Benziv Is there a debate? Thyroid screening Guidelines Targeted case finding criteria Age > 30 years Personal
More informationThyroid Autoantibodies as a Marker of Immunologic Disorder in Women with Unexplained Recurrent Spontaneous Abortion
Med. J. Cairo Univ., Vol. 79, No. 2, September: 139-143, 2011 www.medicaljournalofcairouniversity.com Thyroid Autoantibodies as a Marker of Immunologic Disorder in Women with Unexplained Recurrent Spontaneous
More informationPrevalence of thyroid disorder in pregnancy and pregnancy outcome
Original Research Article Prevalence of thyroid disorder in pregnancy and pregnancy outcome Praveena K.R. 1, Pramod Kumar K.R. 2*, Prasuna K.R. 3, Krishna Kumar TV 4 1 Assistant Professor, Department of
More informationNEWBORN FEMALE WITH GOITER PAYAL PATEL, M.D. PEDIATRIC ENDOCRINOLOGY FELLOW FEBRUARY 12, 2015
NEWBORN FEMALE WITH GOITER PAYAL PATEL, M.D. PEDIATRIC ENDOCRINOLOGY FELLOW FEBRUARY 12, 2015 CHIEF COMPLAINT 35 6/7 week F with goiter, born to a mother with Graves disease (GD) HPI 35 6/7 week F born
More informationThyroid Dysfunction during Pregnancy: A Review of the Current Guidelines
, pp: 130-136 (ISSN: 2455-1716) Impact Factor 2.4 MARCH-2016 Review Article (Open access) Thyroid Dysfunction during Pregnancy: A Review of the Current Guidelines Mustafa Al Abousi* Department of Endocrinology,
More informationMaternal overt and Subclincal hypothyroidism, and the risk of miscarriage in Iraq
International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com DOI: 10.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 5-2018 Research Article DOI: http://dx.doi.org/10.22192/ijarbs.2018.05.05.014
More informationInfluence of screening and intervention of hyperthyroidism on pregnancy outcome
European Review for Medical and Pharmacological Sciences 2017; 21: 1932-1937 Influence of screening and intervention of hyperthyroidism on pregnancy outcome Y. WANG, X.-L. SUN, C.-L. WANG, H.-Y. ZHANG
More informationThyroid Function TSH Analyte Information
Thyroid Function TSH Analyte Information 1 2013-05-01 Thyroid-stimulating hormone (TSH) Introduction Thyroid-stimulating hormone (thyrotropin, TSH) is a glycoprotein with molecular weight of approximately
More informationEffect of mildly elevated thyroid-stimulating hormone during the first trimester on adverse pregnancy outcomes
Li et al. BMC Endocrine Disorders (2018) 18:64 https://doi.org/10.1186/s12902-018-0294-7 RESEARCH ARTICLE Open Access Effect of mildly elevated thyroid-stimulating hormone during the first trimester on
More informationNausea & Vomiting in Pregnancy. Ashley Robbins, MD, FACOG Associate Clinical Professor, KUSM-W
Nausea & Vomiting in Pregnancy Ashley Robbins, MD, FACOG Associate Clinical Professor, KUSM-W Nausea and Vomiting in Pregnancy Prevalence of nausea in pregnancy 50-80% Prevalence of vomiting and retching
More informationClinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy
Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy R. Ju 1, L. Lin 2, Y. Long 2, J. Zhang 2 and J. Huang 2 1 Gynaecology and Obstetrics Department, Beijing Chuiyangliu
More informationMaternal thyroid function at weeks of gestation in fetal trisomies 21 and 18
PRENATAL DIAGNOSIS Prenat Diagn 2011; 31: 33 37. Published online in Wiley Online Library (wileyonlinelibrary.com).2659 Maternal thyroid function at 11 13 weeks of gestation in fetal trisomies 21 and 18
More informationThyroid. Dr Jessica Triay November 2018
Thyroid Dr Jessica Triay November 2018 Hypothyroidism in Pregnancy Clinical update: Hypothyroidism in Pregnancy Take home messages Additional evidence supportive for more relaxed TSH targets for those
More informationThe Number Games and Thyroid Function Arshia Panahloo Consultant Endocrinologist St George s Hospital
The Number Games and Thyroid Function Arshia Panahloo Consultant Endocrinologist St George s Hospital Presentation Today: Common thyroid problems and treatments Pregnancy related thyroid problems The suppressed
More informationGestational Transient Thyrotoxicosis
CLINICAL PRACTICE Gestational Transient Thyrotoxicosis M. Taha Albaar, John MF Adam Department of Internal Medicine, Faculty of Medicine, University of Hasanuddin - Dr. Wahidin Sudirohusodo Hospital. Jl.
More informationIncidence of Hypothyroidism in Antenatal Women with Maternal and Perinatal Outcome
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 4 Ver. III (Apr. 2015), PP 14-18 www.iosrjournals.org Incidence of Hypothyroidism in Antenatal
More informationDAGNOSIS AND TREATMENT OF THYROID GLAND DISEASES IN PREGNANCY GUIDELINE AND RECOMMENDATIONS
Svetlana Spremovic-Radjenovic 1 DAGNOSIS AND TREATMENT OF THYROID GLAND DISEASES IN PREGNANCY GUIDELINE AND RECOMMENDATIONS The field referred to thyroid gland diseases and pregnancy has recorded the fast
More informationROTUNDA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE
This active test table informs the user of Biochemistry tests available in house. s referred to other sites are recorded in the Referred Table. Issue date: 4 TH April 2016 Contact Phone Number ext.1345/2522
More informationThyroid diseases in pregnancy: The importance of anamnesis
Original Article Thyroid diseases in pregnancy: The importance of anamnesis Necati Bulmus 1, Isik Ustuner 2, Emine Seda Guvendag Guven 3, Figen Kir Sahin 4, Senol Senturk 5, Serap Baydur Sahin 6 Open Access
More information344 Thyroid Disorders
344 Thyroid Disorders Definition/Cut-Off Value Thyroid dysfunctions that occur in pregnant and postpartum women, during fetal development, and in childhood are caused by the abnormal secretion of thyroid
More informationAn Approach to: Thyroid Function Tests. Rinkoo Dalan Consultant Department of Endocrinology Tan Tock Seng Hospital
An Approach to: Thyroid Function Tests Rinkoo Dalan Consultant Department of Endocrinology Tan Tock Seng Hospital Regulation of Thyroid axis Hypothalamus TRH T3,T4 ---- TRH Median Eminence (base of brain)
More informationThyroid Disease in Pregnancy. Justin Moore, MD
Thyroid Disease in Pregnancy Justin Moore, MD Case 1 22 yr old G1P0 female at 14 2/7 weeks presents with tremor Weight stable since first positive pregnancy test Some nausea, rare vomiting TSH 0.02 miu/l,
More informationIodine and Thyroid Hormones
Iodine and Thyroid Hormones Iodine and Thyroid Hormones feed-back Iodine Deficiency Characteristics Iodine Deficiency None Mild Mode Severe Median urine iodine >100 50-99 20-49
More informationDecoding Your Thyroid Tests and Results
Decoding Your Thyroid Tests and Results Wondering about your thyroid test results? Learn about each test and what low, optimal, and high results may mean so you can work with your doctor to choose appropriate
More informationDIABETES WITH PREGNANCY
DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal
More informationMaternal outcome in thyroid dysfunction
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Manju VK et al. Int J Reprod Contracept Obstet Gynecol. 2017 Jun;6(6):2361-2365 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172313
More informationThe e-supplementary online content file_1: The Study Protocol
The e-supplementary online content file_1: The Study Protocol Supplement1_English: English Version of the Study Protocol Supplement1_Chinese: Chinese Version of the Study Protocol Supplement1_Ethical Approval:
More informationPregnancy & Thyroid. Zohreh Moosavi Associate professor of Endocriology Imam Reza General Hospital Mashad University. Imam Reza weeky Conferance
Pregnancy & Thyroid Zohreh Moosavi Associate professor of Endocriology Imam Reza General Hospital Mashad University Imam Reza weeky Conferance Objectives Thyroid Disorders & Pregnancy Normal thyroid phsyiology
More information1 day PTA: vaginal spotting, LE edema LMP 6 weeks ago. OSH Clinic: distended abdomen, (+) urine pregnancy; sent home with iron
Anila Bindal, MD 1 day PTA: vaginal spotting, LE edema LMP 6 weeks ago OSH Clinic: distended abdomen, (+) urine pregnancy; sent home with iron UCMC ER: abdomen doubled overnight, significant vaginal bleeding,
More informationCase 1: 24 yo pregnant female presenting with abnormal TFTs and tachycardia RAJESH JAIN ENDORAMA 3/16/2017
Case 1: 24 yo pregnant female presenting with abnormal TFTs and tachycardia RAJESH JAIN ENDORAMA 3/16/2017 Chief Complaint The ER calls about a 24 year old, 12 weeks pregnant. She presented with tachycardia
More informationIntra-amniotic thyroxine to treat fetal goiter
Case Report Obstet Gynecol Sci 2016;59(1):66-70 http://dx.doi.org/10.5468/ogs.2016.59.1.66 pissn 2287-8572 eissn 2287-8580 Intra-amniotic thyroxine to treat fetal goiter Min-Jung Kim 1, Yong-Hwa Chae 2,
More informationClinical THYROIDOLOGY
Clinical THYROIDOLOGY Editor-in Chief Jerome M. Hershman, MD Distinguished Professor of Medicine UCLA School of Medicine and VA Greater Los Angeles Healthcare System Endocrinology 111D, 11301 Wilshire
More informationLABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS
LABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS Maryam Tohidi Anatomical & clinical pathologist Research Institute for Endocrine Sciences THYROID GLAND (15-25 gr), (12-20 gr), 2 lobes connected by
More informationTHE TREATMENT OF HYPOTHYROIDISM IN PREGNANCY
2017 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 24(2):155-160 doi: 10.1515/rjdnmd-2017-0020 THE TREATMENT OF HYPOTHYROIDISM IN PREGNANCY Rucsandra
More informationTHYROID HORMONES: An Overview
1 SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY PBL SEMINAR MBBS III; BMLS & BDS Year 3 What are the Thyroid Hormones? THYROID
More informationTable 1: Thyroid panel. Result (reference interval) TSH 89.5 miu/l ( ) Total T4 5.2 µg/dl ( ) T3 uptake 39% (22-35)
Introduction Thyroid disease is the second most common endocrine disorder (behind diabetes), and its prevalence increases with increasing age. The incidence of newly diagnosed thyroid cancer is increasing
More informationThyroid Disorders Towards a Healthy Endocrine System
Thyroid Disorders Towards a Healthy Endocrine System What are Thyroid Disorders? The thyroid is a butterfly-shaped gland in the middle of the lower neck. Through the release of hormones, the thyroid regulates
More informationObjectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy
Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationIncreased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy
JCEM ONLINE Brief Report Endocrine Care Increased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy Roberto Negro, Alan Schwartz,
More informationEffect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome
ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology
More informationPrevalence of thyroid disorder in pregnancy and pregnancy outcome
Original Research Article Prevalence of thyroid disorder in pregnancy and pregnancy outcome Rama Saraladevi 1*, T Nirmala Kumari 1, Bushra Shreen 2, V. Usha Rani 3 1 Associate Professor, 2 Senior Resident,
More informationStatus of Thyroid Peroxidase Antibodies in Pregnant Women and Association with Obstetric and Perinatal Outcomes in Tertiary Care Center
DOI: 10.7860/NJLM/2017/29019:2255 Obstetrics and Gynaecology Section Original Article Status of Thyroid Peroxidase Antibodies in Pregnant Women and Association with Obstetric and Perinatal Outcomes in
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Hyperthyroidism
Southern Derbyshire Shared Care Pathology Guidelines Hyperthyroidism Purpose of Guideline The management and referral criteria of patients with newly diagnosed hyperthyroidism. Background Hyperthyroidism
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationAlvin C. Powers, M.D. 1/27/06
Thyroid Histology Follicular Cells ECF side Apical lumen Thyroid Follicles -200-400 um Parafollicular or C-cells Colloid Photos from University of Manchester and tutorial created by Dr. James Crimando,
More informationB-Resistance to the action of hormones, Hormone resistance characterized by receptor mediated, postreceptor.
Disorders of the endocrine system 38 Disorders of endocrine system mainly are caused by: A-Deficiency or an excess of a single hormone or several hormones: - deficiency :can be congenital or acquired.
More informationManagement of thyroid diseases in pregnancy
34 Review Management of thyroid diseases in pregnancy 1 2010; 32: 34-38 Introduction Thyroid dysfunction is a common medical problem in pregnancy. Early recognition and optimal management leads to better
More informationTimothy Bilash MD MS OBG Northern Inyo Hospital, Bishop, CA October 20, :30 PM
Thyroxine Deficiency in Pregnancy Timothy Bilash MD MS OBG Northern Inyo Hospital, Bishop, CA October 20, 2006 1:30 PM WHI Estrogen recap In http://courses.washington.edu/bonephys/opestrogen.html. from:
More informationDecreased Birth Weight, Length, and Head Circumference in Children Born by Women Years After Treatment for Hyperthyroidism
ORIGINAL Endocrine ARTICLE Research Decreased Birth Weight, Length, and Head Circumference in Children Born by Women Years After Treatment for Hyperthyroidism Hans Ohrling, Ove Törring, Li Yin, Anastasia
More informationThyroid Function. Thyroid Antibodies. Analyte Information
Thyroid Function Thyroid Antibodies Analyte Information - 1-2013-04-30 Thyroid Antibodies Determination of thyroid autoantibodies are, besides TSH and FT4, one of the most important diagnostic parameters.
More informationLow Concentrations of Maternal Thyroxin During Early Gestation :A Risk Factor of Breech Presentation
Negative feedback CONCENTRATIONS THE IRAQI POSTGRADUATE OF MEDICAL MATERNAL JOURNAL THYROXIN Low Concentrations of Maternal Thyroxin During Early Gestation :A Risk Factor of Breech Presentation Nada Salih
More informationDisclosures. Learning objectives. Case 1A. Autoimmune Thyroid Disease: Medical and Surgical Issues. I have nothing to disclose.
Disclosures Autoimmune Thyroid Disease: Medical and Surgical Issues I have nothing to disclose. Chrysoula Dosiou, MD, MS Clinical Assistant Professor Division of Endocrinology Stanford University School
More informationTHYROID FUNCTION IN MOTHERS WHO GAVE BIRTH TO NEONATES WITH TRANSIENT CONGENITAL HYPOTHYROIDISM
Original Article THYROID FUNCTION IN MOTHERS WHO GAVE BIRTH TO NEONATES WITH TRANSIENT CONGENITAL HYPOTHYROIDISM Gholamreza Asadi Karam 1, Hamid Hakimi 2, Mohsen Rezaeian 3, Abdollah Gafarzadeh 4, Hamidreza
More informationThyroid function in pregnancy
Review Article Page 1 of 16 Thyroid function in pregnancy Ilaria Muller #, Peter N. Taylor #, John H. Lazarus Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine,
More informationHyperthyroidism in a complete molar pregnancy with a mature cystic ovarian teratoma
Simes et al. Thyroid Research (2018) 11:12 https://doi.org/10.1186/s13044-018-0056-7 CASE REPORT Hyperthyroidism in a complete molar pregnancy with a mature cystic ovarian teratoma Bryce C. Simes 1*, Alozie
More informationSlide notes: This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications,
1 This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications, including ophthalmic complications, treatments (both permanent solutions
More informationThyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization
FERTILITY AND STERILITY VOL. 71, NO. 1, JANUARY 1999 Copyright 1998 American Society for Reproductive Medicine ublished by Elsevier Science Inc. rinted on acid-free paper in U.S.A. Thyroid autoimmunity
More informationPostpartum depression- A study from a tertiary care hospital
Original article Postpartum depression- A study from a tertiary care hospital 1Dr.Ramalingam Kolisetty, 2 Dr.Neeli Uma Jyothi 1Professor, Department of Obstetrics & Gynaecology, NRI Medical College 2Associate
More informationReview of unexplained infertility and obstetric outcome: a 10 year review
Human Reproduction Vol.16, No.12 pp. 2593 2597, 2001 Review of unexplained infertility and obstetric outcome: a 10 year review Zabeena Pandian 1, Siladitya Bhattacharya and Allan Templeton Department of
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationReport Information from ProQuest
Report Information from ProQuest 17 May 2015 07:36 17 May 2015 ProQuest Table of contents 1. Antidepressants in pregnancy... 1 17 May 2015 ii ProQuest Document 1 of 1 Antidepressants in pregnancy Author:
More informationHyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease
British Journal of Cancer (211) 14, 1665 1669 All rights reserved 7 92/11 www.bjcancer.com Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease L Walkington
More informationThe impact of an assisted conception unit on the workload of a general gynaecology unit
BJOG: an International Journal of Obstetrics and Gynaecology February 2002, Vol. 109, pp. 207 211 The impact of an assisted conception unit on the workload of a general gynaecology unit Joanne McManus*,
More informationNone. Thyroid Potpourri for the Primary Care Physician. Evaluating Thyroid Function. Disclosures. Learning Objectives
Thyroid Potpourri for the Primary Care Physician Ramya Vedula DO, MPH, ECNU Endocrinology, Diabetes and Metabolism Princeton Medical Group Assistant Professor of Clinical Medicine Rutgers Robert Wood Johnson
More information